Surprising Findings on Cannabis and COVID-19
In a surprising twist, recent studies suggest that cannabis users may have better outcomes when it comes to severe COVID-19 infections. Research shows that people who use cannabis not only have lower rates of severe COVID-19 infections but also experience fewer serious consequences, such as death or extended hospital stays. Let's dive into the details and explore how cannabis might play a role in protecting against the worst effects of this virus.
The Study That Started It All
A groundbreaking study by researchers at Northwell Health in New York, published in the journal Cannabis and Cannabinoid Research, reveals that cannabis users had significantly better outcomes when hospitalized for COVID-19. The study analyzed data from the National Inpatient Sample Database, a comprehensive source of hospital admission records. Patients admitted for COVID-19 were categorized into two groups: cannabis users and non-users. Researchers carefully matched the groups based on factors like age, race, gender, and other health conditions to ensure a fair comparison.
The results were compelling. According to the study, "Cannabis users had better outcomes and lower mortality rates compared with non-users." The researchers speculated that these positive effects might be due to the immunomodulatory properties of cannabis. In simple terms, cannabis might help regulate the immune system in a way that reduces the severity of COVID-19 symptoms.
What the Numbers Say
The study's findings were eye-opening. Initial analysis showed that cannabis users had significantly lower rates of severe COVID-19 infections, including acute respiratory distress syndrome (ARDS), acute respiratory failure, severe sepsis with multiorgan failure, and overall mortality. Cannabis users also had shorter hospital stays compared to non-users.
Even after researchers matched patients 1:1 for age, race, gender, and comorbidities, the results held firm: cannabis use was consistently associated with better outcomes in COVID-19 patients. These findings were first shared in a preliminary form at the annual conference of The American College of Chest Physicians (CHEST) in Honolulu and have since gained traction in the medical community.
How Might Cannabis Help?
So, how exactly could cannabis be influencing these outcomes? Another study from Canada offers some clues. It suggests that cannabinoids might prevent the virus from entering cells, reduce oxidative stress, and help manage the dreaded cytokine storm—a hyperactive immune response that can lead to severe COVID-19 complications. The same study also explored the potential of cannabinoids in treating long COVID symptoms, such as depression, anxiety, post-traumatic stress injury, insomnia, pain, and loss of appetite.
The Canadian research draws on a wide range of existing studies to explore how modulating the endocannabinoid system might affect both early and post-infection stages of COVID-19. Previous studies primarily focused on using cannabis during the acute phase of infection, but this broader approach considers the potential benefits throughout the course of the disease.
Exploring the Science Further
Interestingly, a 2022 study from Oregon State University found that certain cannabinoids, like CBG-A and CBD-A, could potentially prevent COVID-19 from entering human cells. However, it’s important to note that this study was conducted under laboratory conditions and did not assess the effects of smoking or consuming cannabis directly.
Another scientific review highlighted CBD's potential to treat and manage COVID-19 symptoms, alongside other conditions like epilepsy, pain, cancer, schizophrenia, and diabetes. While these findings are promising, they also underscore the need for more extensive research to fully understand the potential role of cannabis in treating or preventing COVID-19.
Separating Fact from Fiction
In the early days of the pandemic, there were numerous unsubstantiated claims about cannabis and COVID-19. Some advocates, like former NFL player Kyle Turley, touted cannabis as a miracle cure. Turley was eventually warned by the FDA and FTC to stop making such claims on social media, as there was no solid evidence to support them at the time.
However, as more research emerges, it’s clear that there could be some legitimacy to the idea that cannabis has a role to play in managing COVID-19. While we must be cautious and not jump to conclusions, studies like those from Northwell Health and Canada provide a foundation for further investigation.
The Bottom Line
While we’re still in the early stages of understanding how cannabis might impact COVID-19 outcomes, recent studies offer some compelling evidence that cannabis users could experience less severe infections and better recovery rates. It seems that cannabis, with its potential immunomodulatory effects, might just have a protective edge when it comes to this virus.
As always, further research is needed to confirm these findings and explore the mechanisms at play. But for now, it’s safe to say that the relationship between cannabis and COVID-19 is a story that’s still unfolding—and it might be worth keeping an eye on as more studies come to light.
Please note: You are not currently logged in. Only members can contribute comments. If you would like to contribute click the button below.
DEC
Tuesday
31
A Dispensary EventDragonfly Wellness |
DragonFly Wellness
Please visit again soon.
We sponsor events throughout the Year
|
||||||
JUL
Monday
21
A Physician EventBryan Doner, DO |
Compassionate Caregivers and Compassionate Certification Centers
PA Medical Marijuana Educational Forum – Cranberry Public Library
Diana Briggs, Founder of PA Compassionate Caregivers and Dr. Bryan Doner, CEO of Compassionate Certification Centers, will give an overview of our PA Medical Marijuana Program. In addition, we will complete the evening with a panel of experts from the MMJ Industry to answer all of your questions.
|